Trial Profile
Phase I/II study of AAV1-FS344 in patients with Becker muscular dystrophy
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs AAV1 FS344 (Primary)
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- 14 Oct 2016 New trial record